rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-2-4
|
pubmed:abstractText |
This study evaluated the 5-year failure rate of naftopidil (NAF) or tamsulosin hydrochloride (TAM) in lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH/LUTS) and compared the prognostic factor of two alpha(1)-blockers.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1651-2065
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
38-45
|
pubmed:meshHeading |
pubmed-meshheading:20095868-Adrenergic alpha-Antagonists,
pubmed-meshheading:20095868-Aged,
pubmed-meshheading:20095868-Aged, 80 and over,
pubmed-meshheading:20095868-Humans,
pubmed-meshheading:20095868-Male,
pubmed-meshheading:20095868-Middle Aged,
pubmed-meshheading:20095868-Naphthalenes,
pubmed-meshheading:20095868-Pilot Projects,
pubmed-meshheading:20095868-Piperazines,
pubmed-meshheading:20095868-Prognosis,
pubmed-meshheading:20095868-Prostatic Hyperplasia,
pubmed-meshheading:20095868-Prostatism,
pubmed-meshheading:20095868-Retrospective Studies,
pubmed-meshheading:20095868-Sulfonamides,
pubmed-meshheading:20095868-Time Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride.
|
pubmed:affiliation |
Department of Urology, Juntendo University Urayasu Hospital, Urayasu City, Japan Urayasu City, Japan. urjunur@sepia.ocn.ne.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|